CELLECTAR BIOSCIENCES
Cellectar Biosciences, a radiopharmaceutical company, designs and develops products to detect, treat, and monitor various human cancers. Its products include 131I-CLR1404, a compound for cancer therapy. The company's product candidates combine lipid-like molecules and phospholipid ethers analogs with radioisotopes to image or destroy malignant cells. Cellectar Biosciences was formerly known as Cellectar, LLC and changed its name in 2008. The company was founded in 2003 and is based in Madison, Wisconsin.
CELLECTAR BIOSCIENCES
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2002-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.cellectar.com
Total Employee:
11+
Status:
Active
Contact:
608-441-8120
Email Addresses:
[email protected]
Total Funding:
33.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-04-12 | Novelos Therapeutics | Novelos Therapeutics acquired by Cellectar Biosciences | 5.13 M USD |
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Cellectar Biosciences
Venture Investors
Venture Investors investment in Post-IPO Equity - Cellectar Biosciences
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Post-IPO Equity - Cellectar Biosciences
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Seed Round - Cellectar Biosciences
Enso Ventures
Enso Ventures investment in Venture Round - Cellectar Biosciences
Venture Investors
Venture Investors investment in Venture Round - Cellectar Biosciences
Advantage Capital
Advantage Capital investment in Venture Round - Cellectar Biosciences
Official Site Inspections
http://www.cellectar.com Semrush global rank: 3.34 M Semrush visits lastest month: 4.79 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
